Condition
Progression of Prostate Cancer
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Unknown2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT01952223Phase 3Active Not Recruiting
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse
NCT03701659Not ApplicableUnknown
TUPKRP Combined With MAB Therapy for LUTS/PCa
NCT01883128Phase 2UnknownPrimary
FOcal RECurrent Assessment and Salvage Treatment
Showing all 3 trials